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Glioma stem cells-derived exosomes promote the angiogenic
ability of endothelial cells through miR-21/VEGF signal
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ABSTRACT
Glioma stem cells (GSCs) play an important role in glioblastoma prognosis.
Exosomes (EXs) mediate cell communication by delivering microRNAs (miRs).
Glioblastoma has a high level of miR-21 which could upregulate vascular endothelial
growth factor (VEGF) expression. We hypothesized GSC-EXs can promote the
angiogenic ability of endothelial cells (ECs) through miR-21/VEGF signal. GSCs were
isolated from U-251 cells with stem cell marker CD133. GSCs transfected without
or with scramble or miR-21 mimics were used to produce GSC-EXscon, GSC-EXssc
and GSC-EXsmiR-21. Human brain ECs were co-cultured with vehicle, GSC-EXscon, GSCEXssc or GSC-EXsmiR-21 plus VEGF siRNAs (siRNAVEGF). After 24 hours, the angiogenic
abilities of ECs were evaluated. The levels of miR-21, VEGF and p-Flk1/VEGFR2 were
determined. Results showed: 1) Over 90% of purified GSCs expressed CD133; 2)
The levels of miR-21 and VEGF in GSCs and GSC-EXs were up-regulated by miR-21
mimic transfection; 3) Compared to GSC-EXscon or GSC-EXssc, GSC-EXsmiR-21 were more
effective in elevating the levels of miR-21 and VEGF, and the ratio of p-Flk1/VEGFR2
in ECs; 4) GSC-EXsmiR-21 were more effective in promoting the angiogenic ability
of ECs than GSC-EXscon or GSC-EXssc, which were remarkably reduced by siRNAVEGF
pretreatment. In conclusion, GSC-EXs can promote the angiogenic ability of ECs by
stimulating miR-21/VEGF/VEGFR2 signal pathway.

INTRODUCTION

cells which display stem cell properties [5, 6] and express
CD133 marker [7, 8]. Increasing evidence suggests that
the aggressiveness and unresponsiveness of glioblastoma
might be related to the presence of GSCs [9, 10]. Indeed,
GSCs can promote tumor angiogenesis [11] and have been
shown to be resistant to cell death following growth factors
withdrawal [12, 13]. Thus, understanding the mechanism
of how GSCs promote metastasis of glioblastoma will be
important for developing efficient therapeutic strategies.
Angiogenesis and extensive invasion are hallmark
features of malignant glioblastoma. As we know,
cancer cells can subvert surrounding normal cells such
as endothelial cells (ECs) to promote tumor growth,
angiogenesis and metastases [14, 15]. Currently,

Glioblastoma is the most common and malignant
brain tumor in adults. Current therapies for glioblastoma
include surgical resection, radiotherapy and chemotherapy.
However, the five-year survival rate for glioblastoma is
less than 5%, and its median survival period is only 14.6
months in adults [1]. The ineffectiveness of the treatments
majorly result from the tumor cellular heterogeneity, the
high migratory capability of glioblastoma and chemoresistance [2].
Cancer stem cells have been suggested to participate
in tumor growth and radio- or chemo- resistance [3, 4].
Glioma stem cells (GSCs) are multipotent tumor-initiating
www.impactjournals.com/oncotarget
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extracellular exosomes (EXs) are emerging as novel
intercellular communicators. Mounting evidence has
shown that EXs can convey cargoes such as proteins and
microRNAs (miRs) to distant/nearby cells and modulate
recipient cell function [16–18]. Exosomal miR-135b
from hypoxia-resistent multiple myeloma cells could
enhance endothelial tube formation under hypoxia [19].
The extracellular vesicles released from glioblastoma cells
have been shown to transfer RNAs to brain microglia/
macrophages [20], suggesting the potential of glioblastoma
in manipulating its environment. Nevertheless, no study
has investigated the potential role of GSC-derived EXs
(GSC-EXs) on EC functions.
As an oncomiR, miR-21 is expressed in a wide range
of cancers. It promotes cell proliferation and migration [2].
Earlier studies have identified that vascular endothelial
growth factor (VEGF) plays a key role in the angiogenesis
process of astrocytoma [21, 22]. Overexpressing miR-21
increased the expression of VEGF in a prostate cell line
and induced tumor angiogenesis [23]. Downregulation
of miR-21 in glioblastoma cells caused repression
of cell growth which theoretically could enhance the
chemotherapeutic effects of cancer therapy [24]. Recently,
another study revealed that GSCs can produce higher
levels of VEGF and contribute to tumor angiogenesis [11].
However, whether EXs-derived from GSCs (GSC-EXs)
can promote the angiogenesis through their carried miRs
and proteins remains unknown.
In this study, we aimed to investigate whether GSCEXs can promote the angiogenic function of ECs through
the miR-21/VEGF signal.

(GSCssc). In addition, we found that miR-21 mimics
elevated the mRNA level of VEGF in GSCs as compared
to that in GSCscon or GSCssc (Figure 2B).

GSC-EXsmiR-21 harbored high levels of miR-21
and VEGF
It is believed that EXs can carry the cargoes such
as miRs and proteins from their parent cells. We focused
on determining the level of miR-21 and VEGF in GSCEXs. First of all, we analyzed the size and concentration
of GSC-EXs and assessed the expression of EX specific
marker CD63 by using NTA. As shown in Figure 3A–
3B, the three types of GSC-EXs displayed a similar size
distribution. The average size was approximately 20-120
nm. There was no difference of the concentration of EXs
in the three groups. According to the fluorescence NTA
results, over 90% of EXs expressed CD63 (Figure 3C).
Next, we examined the levels of miR-21 and VEGF
in GSC-EXs. We found that the EXs-derived from GSCs
transfected with miR-21 mimics (GSC-EXsmiR-21) carried
a higher level of miR-21 and VEGF as compared to that
in the EXs-derived from control GSCs (GSC-EXscon) or
the EXs-derived from GSCs transfected with scramble
control (sc) of miR-21 (GSC-EXssc) (Figure 3D–3E).
Altogether, the levels of miR-21 and VEGF in GSCEXsmiR-21 appeared to be paralleled with their parent cells,
GSCsmiR-21.

GSC-EXsmiR-21 had better effects on elevating
miR-21 level and VEGF secretion of ECs than
GSC-EXscon

RESULTS

Increasing evidence shows that EXs are crucial in
cell-cell communication [16, 27]. To examine whether
GSC-EXs could be up-taken by ECs, the GSC-EXs
were labeled with red fluorescence PKH26 and added
to the culture medium of ECs. As shown in Figure 4A,
the labeled GSC-EXs were observed in the cytoplasm of
ECs, suggesting that the GSC-EXs can be incorporated
into ECs. Meanwhile, our data showed that there was no
significant difference of the fluorescence intensity in ECs
after GSC-EX co-culture, indicating that similar amounts
of GSC-EXs were up-taken by ECs.
Then, we assessed whether GSC-EXs can alter the
levels of miR-21 and VEGF in the recipient cells, ECs.
Our results (Figure 4B) showed that GSC-EXscon or GSCEXssc co-culture alone significantly increased the level
of miR-21 in ECs, and this effect was further enhanced
by GSC-EXsmiR-21. These data suggest that GSC-EXs can
transfer miR-21 to ECs. Similarly, a higher concentration
of VEGF was detected in the culture medium of ECs cocultured with GSC-EXsmiR-21 than those co-cultured with
vehicle (culture medium only), GSC-EXscon or GSCEXssc (Figure 4C). All of these data show that GSC-

Purification of GSCs from U251 cells
The cell surface antigen CD133 is considered
as a marker of stem cells. Indeed, several studies have
demonstrated CD133 can be used to isolate a population
of cells with stem-cell properties [25, 26]. Here, we used
anti-CD133 conjugated beads to isolate GSCs from U251
cells. The purification efficiency was assessed by flow
cytometry. The data (Figure 1) showed that anti-CD133conjugated beads enriched CD133+ cells to 90 ± 6% from
U-251 cells (25 ± 5%).

MiR-21 overexpression increased VEGF mRNA
level in GSCs
The success of miR-21 mimic or inhibitor
transfection was confirmed by qRT-PCR. As shown in
Figure 2A, the level of miR-21 in GSCs was remarkably
up-regulated by miR-21 mimics. There was no significant
difference of the miR-21 level between GSCs in control
(GSCscon) and those transfected with scramble control
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EXsmiR-21 can up-regulate the levels of miR-21 and VEGF
in ECs.

with VEGF siRNA (siRNAVEGF) in ECs. Our data showed
that siRNAVEGF remarkably reduced the angiogenic ability
of ECs elicited by GSC-EXsmiR-21. Altogether, these data
indicate that GSC-EXs increase the angiogenic ability of
ECs through miR-21/VEGF.

GSC-EXsmiR-21 had better effect than GSC-EXscon
on promoting the angiogenic ability of ECs

GSC-EXs activated the VEGF/VEGFR2
pathway in ECs

To further investigate whether miR-21 is involved
in promoting the tube formation and migration abilities of
ECs, we treated ECs with GSC-EXsmiR-21 and its control,
GSC-EXscon or GSC-EXssc or GSC-EXsmiR-21 ko. As shown
in Figure 5, GSC-EXscon or GSC-EXssc alone enhanced the
tube formation and migration abilities of ECs as compared
to the vehicle (culture medium only). What’s more, the
angiogenic ability of ECs was much greatly enhanced by
GSC-EXsmiR-21. In addition, to determine whether VEGF
is involved in the effect of GSC-EXs, we blocked VEGF

It is known that VEGFR2 is responsible for
most downstream angiogenic effects of VEGF in
tumors including migration, invasion, and endothelial
proliferation. For assessing whether the GSC-EX coculture can activate the VEGF/VEGR2 signal, we
measured the phosphorylation of VEGFR2 in ECs. Our
data (Figure 6) showed that both GSC-EXscon and GSC-

Figure 1: MACS purification of GSCs from U-251 cells and characterization of GSCs by flow cytometry. GSCs were
defined as CD133+ cells, which were separated by using MACS and assessed by flow cytometry for determining the efficiency of purification.
(A) representative flow plots showing the percentage of CD133+ cells in U-251 cells and the purified GSCs; left curve: isotype control; right
curve: antibody; (B) summarized data showing the percentage of CD133+ cells before and after MACS; *p < 0.05, vs. U-251 cells. Data are
expressed as mean ± SEM; n = 3/group. MACS: magnetic activated cell sorting.

Figure 2: Up-regulation of miR-21 by miR-21 mimic transfection increased VEGF mRNA expression in GSCs. The

purified GSCs were transfected with miR-21 for 48 hrs, and the levels of miR-21 and VEGF were determined by qRT-PCR. (A–B) the
levels of miR-21 and VEGF in different types of GSCs; *p < 0.05, vs. GSCscon or GSCssc; Data are expressed as mean ± SEM; n = 4/group.
www.impactjournals.com/oncotarget
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EXssc significantly raised the ratio of p-Flk/VEGFR2 in
ECs, which was further enhanced by GSC-EXsmiR-21.

2) miR-21/VEGF/VEGFR2 signaling is the underlying
mechanism of the effects elicited by GSC-EXs.
Cancer stem cells participate in tumor growth and
chemotherapy resistance [3, 4]. Increasing evidence
suggests that the presence of GSCs could result in the
aggressiveness of glioblastoma [9, 10], although the
exact mechanism of how GSCs promote metastasis of

DISCUSSION
The main findings of this study include that 1)
GSC-EXs can promote the angiogenic ability of ECs;

Figure 3: Up-regulation of miR-21 in GSCs by miR-21 mimic transfection increased the levels of miR-21 and VEGF
mRNA expression in GSC-EXsmiR-21. (A) representative NTA plots showing the same pattern of size distribution of the three types
of GSC-EXs; (B) summarized data showing the concentration of EXs. (C) CD63 expression in the collected EXs. *p < 0.05, vs. GSCs;
(D–E) summarized data showing the levels of miR-21 and VEGF in various types of GSC-EXs. *p < 0.05, vs. GSC-EXscon or GSC-EXssc;
Data are expressed as mean ± SEM; n = 4/group.
www.impactjournals.com/oncotarget
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glioblastoma is unclear. CD133 has been well recognized
as a marker for GSCs [25, 26]. We successfully purified
GSCs from U-251 cells by using CD133-conjugated
beads, with the purity > 90% as confirmed by flow
cytometry (Figure 1).
In recent years, increasing evidence indicates that
EXs function as intercellular messengers to facilitate
cancer progression and metastasis [27, 28]. Indeed, tumorderived EXs have been shown to modify healthy cells
by altering their translational profile to promote tumor
progression [29]. Extracellular vesicles derived from
glioblastoma cells could modify recipient cells (endothelial
or monocytes) through transferring proteins and messenger
RNAs and non-coding RNAs [16-18]. In the present study,
we aimed to investigate whether GSC-EXs plays a role in
promoting the angiogenic ability of ECs. Our data (Figure
5) revealed that GSC-EXscon offered a promotion effect on
tube formation and migration ability of ECs, supporting
the notion that EXs released from malignant cells can
affect the function of surrounding cells.
It is known that extensive angiogenesis and
invasion are two typical features of glioblastoma. The
pro-angiogenic role of miR-21 has been indicated in
a previous study showing that knock-down of miR-21

decreased neointimal hyperplasia following angioplasty
[30]. Increasing evidence shows that the level of miR21 is significantly elevated in human cancers include
glioblastoma and melanoma [31, 32]. It is known
that miRs transferred via EXs could mediate cell-cell
communication, however, whether GSC-EXs can transfer
miR-21 to interfere the angiogenic ability of ECs remains
unknown. In order to explore the role of miR-21 in
angiogenic ability of ECs promoted by GSCs-EXs, we
overexpressed miR-21 in GSCs to obtain miR-21 enriched
EXs (GSC-EXsmiR-21). The miR-21 level in GSCs and
the correspond EXs was verified by qRT-PCR. Our data
showed that miR-21 level was elevated in GSC-EXsmiR-21,
which paralleled with their parent cells, GSCsmiR-21
(Figures 2 and 3), suggesting the success of transfection.
Previous studies have revealed that VEGF is involved in
EC recruitment, proliferation and vasculature formation
to support the expansion of malignant tumors [33, 34]. In
this study, we found that the mRNA level of VEGF was
increased in GSC-EXsmiR-21 (Figure 2). This is in consistent
with previous studies showing that miR-21 can enhance
VEGF expression [23, 28].
In order to elucidate whether GSC-EXs co-culture
can affect the miR-21 level and VEGF secretion of ECs,

Figure 4: Incorporation of various GSC-EXs into ECs and GSC-EXsmiR-21 had better effects on increasing miR-21
level and VEGF secretion of ECs. (A) left: representative images showing the incorporation of GSC-EXs into ECs; bar: 100 µm;
red: PKH26 labeled GSC-EXs; blue: DAPI counterstained nucleus; right: summarized data showing the fluorescence intensity in ECs cocultured with the three types of GSC-EXs; (B) summarized data showing the level of miR-21 in ECs co-cultured with the three types of
GSC-EXs; (C) summarized data showing the concentration of VEGF in the culture medium of ECs co-cultured with GSC-EXs. *p < 0.05,
vs. vehicle; +p < 0.05, vs. GSC-EXscon or GSC-EXssc; Data are expressed as mean ± SEM; n = 4/group.
www.impactjournals.com/oncotarget

36141

Oncotarget

Figure 5: GSC-EXsmiR-21 had better effects than GSC-EXscon and GSC-EXssc on promoting the angiogenic ability
of ECs. (A) representative images and the summarized data showing the tube formation ability of ECs treated by various types of GSCEXs; bar: 500 µm; (B) summarized data showing the migration ability of ECs in different treatment groups. *p < 0.05, vs. vehicle; +p < 0.05,
vs. GSC-EXscon or GSC-EXssc; #p < 0.05, vs. GSC-EXsmiR-21 or GSC-EXsmiR-21+siRNAsc. Data are expressed as mean ± SEM; n = 4/group.
www.impactjournals.com/oncotarget
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we directly cultured ECs in the presence of different types
of GSC-EXs. Our results demonstrated that the PKH26
labeled GSC-EXs were up-taken by ECs after co-culture
(Figure 4). More importantly, we found that the GSCEXsmiR-21 can remarkably increase miR-21 level in ECs,
suggesting that the GSC-EXsmiR-21 can delivery miR-21
to ECs. Meanwhile, we found the level of VEGF in the
culture medium of ECs was significantly elevated after
the incubation with GSC-EXsmiR-21(Figure 4). The elevated

level of miR-21 could be attributed to the directly delivery
of VEGF via GSC-EXsmiR-21 and/or through the secretion
of VEGF of ECs enhanced by GSC-EXsmiR-21. This data
was supported by a previous report showing that exosomal
miR-21 can activate STAT3 to increase VEGF secretion of
human umbilical vein ECs [28].
For further assess whether GSC-EXs miR-21 harboring
high levels of miR-21 and VEGF can promote the
angiogenesis response, ECs were evaluated by using tube

Figure 6: GSC-EXsmiR-21 had better effect than GSC-EXscon and GSC-EXssc on activating the VEGF/VEGFR2
signal in ECs. (A) representative bands showing the expressions of VEGFR2 and its phosphorylation in ECs; (B) summarized data

showing the ratio of p-Flk1/VEGFR2. * p < 0.05, vs. vehicle; +p < 0.05, vs. GSC-EXscon or GSC-Exssc. Data are expressed as mean ± SEM;
n = 4/group.
www.impactjournals.com/oncotarget
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Purification of GSCs with CD133-conjugated
microbeads from glioblastoma cells by using
magnetic activated cell sorting

formation assay. The results revealed that GSC-EXscon
and GSC-EXssc alone can promote tube formation on
the matrigel, and GSC-EXsmiR-21 exhibited the best effect
(Figure 5). These data were supported by a previous report
showing that the extracellular vesicles derived from U251
cells had the ability to stimulate EC activities [35]. The
proved pro-angiogenic ability of GSC-EXs could be
explained, at least partially, was attributed to their miR21 and VEGF contents. VEGF is well known as a proangiogenic factor [36]. Its release by tumor cells as a
component of membrane vesicles has been highlighted
[37]. In order to verify the role of VEGF in promoting
EC angiogenesis, we knocked down VEGF by using
siRNAVEGF and observed that a significantly less amount
of tubes were formed by ECs, reflecting that VEGF is
involved in GSC-EXs mediated endothelial angiogenesis.
It is believed that VEGFR2 is responsible for
most downstream angiogenic effects of VEGF including
changes in vascular permeability, endothelial proliferation,
invasion, migration, and survival [38]. Binding of VEGF to
VEGFR2 can activate downstream survival and migration
pathways involving PI3-kinase/Akt and focal adhesion
kinase [39]. In the present study, our results indicate that
the ratio of p-Flk1/VEGFR2 was significantly elevated in
ECs co-cultured with the GSC-EXsmiR-21 (Figure 6). These
data reflect that the VEGF/VEGFR2 signal was activated
in ECs after the incubation with GSC-EXs.
Altogether, our results indicate that GSC-EXs
fully equipped for angiogenesis stimulation through their
carried miR-21 and pro-angiogenic growth factor VEGF to
activate the angiogenic ability of ECs. These data suggest
an important role for GSCs in tumor angiogenesis and in
elucidation of the mechanistic basis which will benefit the
development of novel therapeutic strategies. However,
in vivo research should be done for further studying the
effects of GSC-EXs in tumor metastasis.

CD133 has been used to enrich the putative
cancer stem cells [25, 26]. In this study, the anti-CD133conjugated microbeads were applied to isolate GSCs
from U-251 cells by using magnetic activated cell sorting
(MACS) as previously reported with slight modification
[40]. In brief, U-251 MG cells were incubated with
anti-CD133-conjugated microbeads antibody (10 µl
anti-CD133 microbeads per 107 U251 cells) in 100 µl
reaction volume for 20 mins in the refrigerator. Then, the
CD133+ cells were collected by using a magnet separator
(DynaMag-2 magnet; Thermo scientific). The purity of
GSCs was confirmed by flow cytometry analysis. The
purified GSCs were expanded in DMEM/F12 medium
containing 2% B27 (without retinoic acid), EGF (20 ng/
ml), FGF-2 (20 ng/ml), heparin (5 µg/ml), glutamine (2
mM) and 1% antibiotics.
For flow cytometry analysis, the purified GSCs
and U-251 MG cells were washed with PBS twice, and
then incubated with FITC-conjugated CD133 (5 µl/1x106
cells, Miltenyi Biotec), or isotype control antibody (FITCconjugated IgG, 20 µl/1x106 cells, BD biosciences) for
30 mins in the dark. After incubation, the samples were
analyzed under flow cytometry (BD C6 flow cytometer).
10,000 events were collected for analysis. The experiment
was repeated three times.

Cell transfection
The purified GSCs were expanded and used
for miR-21 mimics transfection to overexpress miR21 [41]. Briefly, the GSCs were cultured to 60–70%
confluence, and transfected with miR-21 mimics or
the SC of miR-21 (40 nM, Thermo Fisher Scientific,
Waltham, MA) by using lipofectamine 2000 (Invitrogen,
Carlsbad, CA) for 48 hrs according to the manufacturer’s
instruction. The sequences of miR-21 mimics were: sense
5′-UAGCUUAUCAGACUGAUGUUGA-3′; antisense
5′-AACAUCAGUCUGAUAAGCUAUU-3′.
GSCs
transfected with miR21 SC or mimics or inhibitors were
denoted as GSCssc or GSCsmiR-21, respectively. GSCs
cultured in complete culture medium served as control
(GSCscon). The levels of miR-21 and protein in GSCs were
extracted after transfection, respectively. The experiment
was repeated four times. The three types of GSCs were
used for producing corresponding EXs.

MATERIALS AND METHODS
Cell culture
Human GBM cell line U-251 cells were purchased
from ATCC (Manassas, VA, USA). The cells were cultured
with DMEM medium supplemented with 4.5g/L glucose,
2 mM L-glutamine and 10% fetal bovine serum (FBS)
according to the manufacture’s instruction. Medium was
replaced twice a week.
Human brain ECs were purchased from Cell
systems (Kirkland, WA, USA) and cultured according to
the manufacturer’s protocol. In brief, ECs were cultured
in CSC complete medium containing 10% serum, 2%
human recombinant growth factors, and 0.2% antibiotic
solution under standard cell culture conditions (5%
CO2, 37°C). All medium and supplement reagents were
purchased from Cell Systems. Medium was changed
twice a week.
www.impactjournals.com/oncotarget

Preparation and collection of EXs released from
GSCs
The protocol for collecting EXs from serumfree conditionl medium (CM) has been reported in our
previous study [42]. Briefly, GSCscon, GSCssc, GSCsmiR-21
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or GSCsmiR-21 were cultured in CM composed of
DMEM medium supplemented with 4.5g/L glucose, 2
mM L-glutamine to release EXs which were denoted as
GSC-EXscon, GSC-EXssc or GSC-EXsmiR-21. After 24 hrs,
the respective CM was collected and centrifuged at 300g,
15 mins to remove dead cells. The supernatants were
centrifuged at 2000 g, 30 mins to remove cell debris,
followed by centrifugation at 20,000 g, 70 mins, and
ultracentrifugation at 170,000 g, 90 mins to pellet EXs. The
pelleted EXs were resuspended with phosphate-buffered
saline (PBS) and aliquoted for nanoparticle tracking
analysis (NTA) and co-culture experiments. PBS was
filtered through 20 nm-filter (Whatman, Pittsburgh, PA).

Image J (NIH) according to the instruction and a previous
report [43]. Briefly, the cell of interest and a region next
to the cell of interest that has no fluoresce (considered
as background) were selected. The area, integrated
density and mean gray value were measured. The cellular
fluorescence was calculated as: cellular fluorescence =
integrated density - (area of the selected cell x fluorescence
of background readings). The fluorescence intensities of
one hundred cells in five random fields in each group were
averaged. The experiment was repeated four times.
To further elucidate whether GSC-EXs can alter
the function of ECs, ECs were divided into five groups
and co-cultured with: vehicle (co-culture medium
only), GSC-EXscon, GSC-EXssc, GSC-EXsmiR-21 ko, GSCEXsmiR-21. The work concentration of GSC-EXs (50 μg/
ml) was determined based on our previous study [16].
Some ECs were pre-transfected with VEGF siRNA
(siRNAVEGF; 50 nM; Qiagen) using oligofectmanine
transfection reagent (Invitrogen, Carlsbad, CA) for 48 hrs
to knock out the endogenous VEGF, and then co-cultured
with GSC-EXsmiR-21. Scrambled siRNA (siRNAsc; 50 nM;
Qiagen) was used as an experimental control. After 24
hrs, the culture medium of ECs were collected for VEGF
analysis. The miR-21 level in ECs was analyzed by
quantitative RT-PCR analysis. ECs were used for tube
formation and migration assays. The experiment was
repeated four times.

ko

Nanoparticle tracking analysis of GSC-EXs
The NanoSight NS300 (Malvern Instruments,
Malvern, UK) was used to analyze the size, concentration
and CD63 expreesion of EXs at light-scatter or
fluorescence-scatter mode as we previously reported
[42]. Briefly, for size and concentration detection, the
collected EXs were resuspended with 700 ul filtered
PBS and analyzed under light-scatter mode of NTA. For
detection of CD63 expression in EXs, the collected EXs
were incubated with CD63-conjugated microbeads (10
ul; Miltenyi Biotec) in a 100 µl reaction volume for 2
hrs. Then, a magnet module (DynaMag-2 magnet; Life
technology) was applied to separate CD63+ EXs from the
total EX suspension. After an overnight magnet separation,
the CD63+ EXs were resuspended with 100 µl filtered PBS
and incubated with rabbit anti-goat IgG conjugated with
Q-dot 655 (1:350; Life Technologies) for 90 mins at RT.
All samples were analyzed under fluorescence-scatter
mode of NTA. Three videos of typically 30 seconds
duration were taken, with a frame rate of 30 frames per
second. Data was analyzed by NTA 3.0 software (Malvern
Instruments, Malvern, UK) on a frame-by-frame basis.
The experiment was repeated four times.

Quantitative RT-PCR analysis
After transfection, cells were washed with 1xPBS.
The total mRNA from GSCs was extracted using and
lysed in Trizol (Thermo Fisher Scientific, Waltham,
MA). The miRs from GSCs, and from ECs co-cultured
with different types of GSC-EXs were extracted using
mirVana miRNA Isolation kit (Qiagen). For detecting
miR-21 level, reverse transcription (RT) reactions
were performed by using mirVana qRT-PCR miRNA
Detection Kit and hsa-miR-21 qRT-PCR primer set
from Ambion. The forward primer of miR-21 was:
5′-TTTTGTTTTGCTTGGGAGGA-3′, the reverse primer
of miR-21 was: 5′-AGCAGACAGTCAGGCAGGAT-3′.
For measuring the mRNA level of VEGF in GSCs,
RT was performed by using the first strand cDNA
synthesis kit (Qiagen) according to manufacturer’s
instruction. The forward primer of VEGF was,
5′-CGAGGGCCTGGAGTGTG-3′, the reverse primer
of VEGF was, 5′-CCGCATAATCTGCATGGTGAT-3′.
The expression of U6 was used as endogenous control
for each sample. The forward primer of U6 was:
5′-CTCGCTTCGGCAGCACA-3′, the reverse primer of
U6 was: 5′-AACGCTTCACGAATTTGCGT-3′. Relative
expression level of each gene was normalized to U6 and
calculated using the 2-ΔΔCT method. The experiment was
repeated four times.

Co-culture of GSC-EXs with ECs
In order to determine whether GSC-EXs can be uptaken by ECs, the three types of GSC-EXs were labeled
with PKH 26 and co-cultured with ECs [16]. In brief,
GSC-EXs were labeled with PKH 26 (2 × 10−6 M, SigmaAldrich) for 5 mins at 37 °C, followed by wash with 1 x
PBS and ultracentrifuged at 170,000g for 90 mins. After
that, GSC-EXs (50 µg) were resuspended and added to
the culture medium (1 ml) of ECs for co-culture. After
24 hrs, ECs were washed with PBS for twice, and the
nuclei of ECs were stained with DAPI (1 μg/ml, Wako
Pure Chemical Industries Ltd) for 2 mins. Incorporation
of GSC-EXs into ECs was observed by fluorescence
microscopy (EVOS; Thermo Fisher Scientific). The
level of cellular fluorescence intensity was analyzed by
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Enzyme-linked immunosorbent assay

Statistical analysis

The level of VEGF in the culture medium of ECs cocultured with the three types of GSC-EXs were measured
by enzyme-linked immunosorbent assay (ELISA)
according to the manufacturer’s instructions (R&D
Systems). The concentration of VEGF was calculated as
pg/ml of culture medium. The experiment was repeated
four times.

Data is expressed as mean ± SEM. Two group
comparison was analyzed by Student’s t test. Multiple
comparisons were analyzed by one- or two-way
ANOVA followed by LSD post-hoc test. SPSS 17.0
statistical software was used for analyzing the data. For
all measurements, a p < 0.05 was considered statistic
significant.

Migration and tube formation assay for ECs
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